ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 85 filers reported holding ALLOVIR INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,742 | +0.8% | 43,601 | +59.5% | 0.00% | – |
| Q2 2023 | $92,963 | -15.5% | 27,342 | -2.1% | 0.00% | – |
| Q1 2023 | $110,056 | -28.5% | 27,933 | -6.9% | 0.00% | – |
| Q4 2022 | $153,946 | +38.7% | 30,009 | +113.3% | 0.00% | – |
| Q3 2022 | $111,000 | +37.0% | 14,070 | -32.0% | 0.00% | – |
| Q2 2022 | $81,000 | -48.7% | 20,683 | -11.5% | 0.00% | – |
| Q1 2022 | $158,000 | -88.9% | 23,361 | -78.8% | 0.00% | – |
| Q4 2021 | $1,427,000 | +302.0% | 110,291 | +679.7% | 0.00% | – |
| Q3 2021 | $355,000 | +9.2% | 14,145 | -14.0% | 0.00% | – |
| Q2 2021 | $325,000 | -56.0% | 16,454 | -47.8% | 0.00% | – |
| Q1 2021 | $738,000 | +583.3% | 31,513 | +1026.3% | 0.00% | – |
| Q4 2020 | $108,000 | +300.0% | 2,798 | +180.1% | 0.00% | – |
| Q3 2020 | $27,000 | – | 999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $28,611 | 1.60% |
| GMT CAPITAL CORP | 2,758,846 | $14,152,880 | 0.65% |
| SVB FINANCIAL GROUP | 43,019 | $220,687 | 0.60% |
| Regency Capital Management Inc.\DE | 75,025 | $384,878 | 0.44% |
| Redmile Group, LLC | 1,907,969 | $9,787,881 | 0.40% |
| Samsara BioCapital, LLC | 82,336 | $422,384 | 0.09% |
| Alkeon Capital Management | 4,605,104 | $23,624,184 | 0.09% |
| Woodline Partners LP | 1,087,090 | $5,576,772 | 0.08% |
| XTX Topco Ltd | 53,422 | $274,055 | 0.06% |
| Virtus ETF Advisers LLC | 20,906 | $107,248 | 0.06% |